BACKGROUND: Traditional measures of ARDS severity such as PaO 2 /FIO 2 may not reliably predict clinical outcomes. The oxygenation index (OI [FIO 2 Â mean airway pressure Â 100)/ PaO 2 ]) may more accurately reflect ARDS severity but requires arterial blood gas measurement. We hypothesized that the oxygenation saturation index (OSI [FIO 2 Â mean airway pressure Â 100)/oxygen saturation by pulse oximetry (SpO 2 )]) is a reliable noninvasive surrogate for the OI that is associated with hospital mortality and ventilator-free days (VFDs) in patients with ARDS.
Although it has been nearly 50 years since the first description of ARDS, 1 predicting the outcome of patients with ARDS continues to be a challenge. A recent international, multicenter observational cohort study found that morbidity and mortality from ARDS remain high. 2 Furthermore, interventions to improve outcomes are largely limited to supportive measures such as lung-protective ventilation strategies, 3 differential positive end-expiratory pressure (PEEP) strategies, 4 and prone positioning. 5 One potential reason for the dearth of effective therapies is the lack of simple, reliable methods for risk stratification at the bedside that will help target therapies to the most severely ill patients. Although several measures, such as the ratio of PaO 2 to FIO 2 and the Lung Injury Score (LIS), have traditionally been used in both clinical practice and clinical trials, these offer limited prognostic information or require arterial blood gas analysis, [6] [7] [8] [9] [10] [11] highlighting the need for simple, noninvasive predictive measures.
Both current and previous ARDS definitions have attempted to incorporate severity assessments to reflect prognosis. The Berlin definition of ARDS 12 addresses some of the challenges and drawbacks of the AmericanEuropean Consensus Conference (AECC) definition. 13 For example, the Berlin definition includes a minimum PEEP value to account for the effect of mechanical ventilator settings on PaO 2 /FIO 2 . Despite these improvements, however, the Berlin definition is only slightly better than the AECC definition for prognostication in ARDS (area under the receiveroperating characteristic curve [AUC], 0.577 vs 0.536). 12 This scenario may be partially related to the dependence of both the AECC and Berlin definitions on PaO 2 /FIO 2 as the primary measure of ARDS severity. Multiple studies have shown that PaO 2 /FIO 2 is not an independent predictor of mortality in patients with ARDS in multivariate analyses that control for other measures of severity of illness. 7, 10, 14 The PaO 2 /FIO 2 does not reflect other aspects of the severity of acute lung injury such as mechanical ventilation settings, changes in lung compliance, and pulmonary shunt. 6, 11, 15, 16 A measure that better accounts for these factors is the oxygenation index (OI), measured as follows: FIO 2 /PaO 2 Â mean airway pressure (MAP) Â 100. The OI was first investigated as a prognostic tool for acute hypoxemic respiratory failure in pediatric populations 17 and has since been shown to be an independent risk factor for mortality in adults with ARDS. 14, 16, 18, 19 As with the PaO 2 /FIO 2 , however, this measure relies on invasive blood gas monitoring. Assessment of the severity of hypoxemia by using noninvasive pulse oximetry (SpO 2 /FIO 2 ) has been used as a substitute for PaO 2 /FIO 2 in Sequential Organ Failure Assessment scoring 20 and can be used for ARDS diagnosis. 21, 22 In pediatric patients, the oxygenation saturation index (OSI), measured as (FIO 2 Â MAP Â 100)/SpO 2 , was as effective as the OI in predicting mortality, and saturation-based measurements identified more patients with ARDS than those identified on the basis of blood gas analysis. 23 Based on these findings, we hypothesized that the OSI is a noninvasive surrogate for OI in adults with ARDS that is associated with increased mortality and a reduction in ventilator-free days (VFDs).
Methods

Study Design
This trial was a nested retrospective cohort study of patients prospectively enrolled in the Validating Acute Lung Injury Markers for Diagnosis (VALID) study. Patients who were eligible for enrollment in VALID were $ 18 years old and admitted to the Vanderbilt University Medical Center medical, surgical, cardiovascular, or trauma ICU for at least 2 days. Full inclusion and exclusion criteria have been previously described elsewhere. 24 Written informed consent was obtained at the time of enrollment from the patients or a surrogate when possible. Because the study poses minimal risk to patients, the Vanderbilt University institutional review board approved the study protocol with a waiver of informed consent if the patient was unable to consent and no surrogate was available (Vanderbilt institutional review board no. 051065).
Study Population
Patients meeting inclusion criteria for VALID were further eligible for the current study if they developed ARDS (Berlin criteria) 12 A total of 329 patients were included in the final analysis (Fig 1) . In general, these patients were managed with a lower PEEP/FIO 2 titration strategy and low tidal volume with plateau pressures of < 30 cm H 2 O. Data were not collected on use of prone positioning but it was used only rarely.
Data Collection
Demographic data, prehospital medications, medical history, and admission diagnoses were collected at VALID enrollment. Clinical data such as hemodynamic variables, ventilator settings, laboratory values, and in-hospital medications were collected daily for the first 4 days in the ICU. These values were used to calculate illness severity scores (Acute Physiology and Chronic Health Evaluation II [APACHE II] and Simplified Acute Physiology Score II). The lowest PaO 2 /FIO 2 and SpO 2 /FIO 2 were recorded from each ICU day. Pulse oximetry data was only used to calculate an SpO 2 /FIO 2 ratio if the minimum saturation from that day was < 97%. 21 Diagnoses of ARDS, sepsis, and organ dysfunction were made during the first 4 days of ICU admission by consensus of two physician investigators according to consensus definitions. 25, 26 Outcomes, including length of hospital stay, length of ICU admission, VFDs (defined as the number of days alive and off mechanical ventilation in the 28 days following study enrollment), 27 and hospital mortality, were collected. All available MAP values in the electronic medical record were filtered to select for the highest available measurement on the day of ARDS diagnosis.
The OI and OSI were calculated for each patient by using the following formulas:
Statistical Analysis
Normally distributed continuous variables are presented as mean AE SD, and nonnormally distributed continuous variables are presented as medians with interquartile ranges (IQRs 
Results
Patient Characteristics
A total of 329 patients met inclusion criteria for this study. Demographic characteristics and clinical data are described in Table 1 . Predicted body weights were not available in the VALID study. Average tidal volume/ kilogram (based on actual weight on day of diagnosis as we did not have height available for all patients to calculate ideal body weight) was 5.7 AE 1.9 cc/kg. The highest PEEP value on the day of ARDS diagnosis was 10 AE 4 cm H 2 O.
OI and OSI Are Strongly Correlated With Each Other
In this cohort of patients, OI and OSI were strongly correlated (Spearman rho ¼ 0.862; P < .001) (Fig 2) , suggesting that the OSI, which is continuously available through noninvasive measures, is a reliable surrogate for the OI in adult patients with ARDS.
Clinical Outcomes Are Associated With OI and OSI chestjournal.org quintile of OSI in Figure 3 (P ¼ .012). In a multivariable logistic regression controlling for age, sex, and APACHE II score, OSI was independently associated with mortality ( 
OI and OSI Improve Prognostic Discrimination
We tested the individual performance of OSI, OI, PaO 2 / FIO 2 , SpO 2 /FIO 2 , and LIS to predict hospital mortality by calculating the AUC (Table 4 ). The OSI (AUC, 0.602), OI (AUC, 0.562), and SpO 2 /FIO 2 (AUC, 0.595) had moderate performance for mortality prediction, although the AUC for OI did not reach statistical significance. We also computed the AUC for APACHE II, which was shown in a single-center observational study to be a significant predictor of mortality in (Fig 4) .
Discussion
In 329 adults with ARDS who were mechanically ventilated, the OSI was highly correlated with the OI. Both the OSI and the OI were independently associated with fewer VFDs, whereas the traditional metric for characterizing ARDS severity, PaO 2 /FIO 2, was not. Among the ARDS severity measures analyzed, only OSI was significantly associated with mortality in this cohort. Furthermore, both OSI and OI were superior to the PaO 2 /FIO 2 in prognostic performance. Based on analysis of receiver-operating curves, the OSI may have stronger performance than the OI, as the latter did not reach statistical significance for mortality prediction.
The results of our study reinforce the value of using a noninvasive saturation-based measurement when clinically appropriate. As previously described, relying on arterial blood gas measurements for the diagnosis of ARDS may contribute to its underrecognition by clinicians. 2, 21, 23 Furthermore, repeated blood draws in the ICU setting contribute to iatrogenic anemia, need for blood transfusions, increased risk of infection, and higher cost of care. 29 Aside from decreasing harm, saturation-based measurements are continually available in almost all hospital settings, including relatively resource-poor ones such as developing countries. Rice et al 21 and others have described the role that saturation-based measurements play in the diagnosis of ARDS, 22 and our study showed that saturation-based measurements are useful not only for diagnosis but also for prognostication.
In this cohort, PaO 2 /FIO 2 on the day of ARDS diagnosis was not independently associated with clinical outcomes, whereas the saturation-based predictors (SpO 2 /FIO 2 and OSI) and the OI were. Because we excluded patients for whom either PaO 2 /FIO 2 or SpO 2 / FIO 2 was not calculable, the difference cannot be explained simply by which patients had a blood gas sample drawn and which did not. One potential explanation is that saturation-based measurements are more sensitive for detecting changes in oxygenation that will affect a patient's clinical course because they are continuously available rather than intermittently available. A strength of using the OSI rather than the SpO 2 /FIO 2 alone is its incorporation of MAP, which provides a more complete estimate of the extent of acute lung injury by reflecting not only oxygenation deficit but also aggressiveness of respiratory support and changes in lung compliance. Figure 3 -Percent hospital mortality according to oxygenation saturation index quintile (P ¼ .012).
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To the best of our knowledge, the present study is the first to investigate the OSI in adults. This research expands on the work of Khemani et al, 23 which showed that average saturation-based measurements on the first day of ARDS diagnosis were more predictive of mortality than arterial blood gas-based measurements when diagnosing ARDS in children for whom both arterial blood gas and pulse oximetry data were available. In children for whom pulse oximetry data were not available, saturation-based measurements had similarly strong prognostic value. In the present cohort, the OSI exhibited improved performance for mortality prediction among patients aged < 40 years. The OSI may be particularly useful in these younger patients with ARDS, who are less likely to have complex comorbidities that affect clinical outcomes. The present study has several strengths. The VALID cohort is a prospectively enrolled cohort with highquality data, including very detailed phenotyping for ARDS. The large cohort size for the present study and the use of data that were collected for clinical indications rather than research purposes enhance the potential generalizability of the study. There are also some limitations, however. First, patients whose minimum This criterion excluded from our study 86 patients in VALID who met the Berlin criteria of ARDS according to the PaO 2 /FIO 2 ratio. Thirty-two additional patients were excluded who did not have a recorded SpO 2 /FIO 2 ratio on the day of ARDS diagnosis. We also only investigated the prognostic value of OI and OSI on the day of ARDS diagnosis and did not account for any information that could be gleaned from changes in these values over time. We focused on the day of ARDS diagnosis because the number of patients who had arterial blood gas analysis for calculation of OI on subsequent days was low, limiting power. Gajic et al 14 reported that changes in variables (including the OI) over 3 days provides more prognostic information than the same data from the first day alone.
A potential limitation of our primary end point of hospital mortality is that it does not account for patients who were terminally ill and were discharged to another inpatient facility or hospice care and died shortly thereafter. However, OI and OSI were also associated with VFDs as a secondary end point, a respiratorycentered end point that may be more relevant to ARDS outcomes. Future studies could include a time-to-death analysis. In addition, the association between OSI and mortality was not statistically significant in patients without severe sepsis, which likely reflects a low event rate in nonseptic patients (17% mortality) rather than an inherent weakness of the OSI. Lastly, our study population was predominantly composed of white, male trauma patients. A larger, multicenter prospective study with a more heterogeneous population is necessary to validate our results.
Conclusions
Measurement of the OSI on the day of ARDS diagnosis performed as well as the OI in predicting clinical outcomes, was simple to calculate and continuously available, and offered more prognostic information than traditional measures of ARDS severity such as PaO 2 /FIO 2 , while avoiding invasive arterial blood gas monitoring. Figure 4 -Receiver-operating characteristic (ROC) curve for mortality prediction. Red: ROC curve for the oxygenation saturation index (P ¼ .007) for the entire cohort. Blue: ROC curve for Acute Physiology and Chronic Health Evaluation II scores (P < .001) for the entire cohort. Gray: ROC curve for the oxygenation saturation index (P < .001) for patients aged < 40 years. Orange: ROC for PaO 2 /FIO 2 (P ¼ .206).
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